Completed OBSERVATIONAL NCT04445506

Short Term Corticosteroids in SARS-CoV2 Patients

The Effect of the Short-term Use of Systemic Corticosteroids in COVID-19 Patients in Regard to Hospital Length of Stay, Morbidly and/or Mortality.

Sponsor: The Miriam Hospital

Conditions Corticosteroids Covid19 Dexamethasone SARS-CoV 2 Steroids

Interventions Dexamethasone

Updated 4 times since 2020 Last updated: Jun 22, 2020 Started: Apr 1, 2020 Primary completion: May 31, 2020 Completion: May 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Corticosteroids and Covid19, this trial is completed. The trial is conducted by The Miriam Hospital and has accumulated 4 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jul 2020 — Jan 2021 [monthly]

Completed

First recorded

Apr 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Miriam Hospital

Data source: The Miriam Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Providence, United States